文献速递静脉血栓栓塞

利伐沙班诱导深静脉血栓患者发生眼肌型重症肌无力

Ocular Myasthenia Induced by Rivaroxaban in Patient with Deep Vein Thrombosis.
PubMed 文献 · Ann Vasc Surg · 2018-02-16

一例60岁男性深静脉血栓患者服用利伐沙班后出现双侧上睑下垂,血清抗乙酰胆碱受体抗体阳性确诊重症肌无力,停用利伐沙班后眼肌症状逆转,但上睑下垂复发需长期口服溴吡斯的明。作者称这是文献中首例利伐沙班所致眼肌型重症肌无力,机制可能与抗体交叉反应或T细胞激活有关。

要点

  • 利伐沙班治疗深静脉血栓期间出现双侧上睑下垂需警惕重症肌无力。
  • 血清抗乙酰胆碱受体抗体阳性可确诊,停用利伐沙班后眼肌症状可逆转。
  • 停用利伐沙班后上睑下垂仍可能复发,部分患者需长期溴吡斯的明治疗。

核心结论

  • 作者称这是文献中首例利伐沙班给药所致眼肌型重症肌无力的报告。
  • 尽管利伐沙班有获益,但需识别其意外免疫相关不良事件。

研究设计与样本

  • 本文为单个病例报告,患者为60岁男性。

主要发现

  • 60岁男性因深静脉血栓服用利伐沙班后主诉双侧上睑下垂,血清抗乙酰胆碱受体抗体试验阳性确诊重症肌无力,未发现纵隔胸腺瘤。
  • 停用利伐沙班后眼肌型重症肌无力逆转,但上睑下垂复发,需长期口服溴吡斯的明治疗。

关键数值与推荐

  • 重症肌无力经血清抗乙酰胆碱受体抗体试验阳性确诊,未发现纵隔胸腺瘤。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The non-vitamin K antagonist oral anticoagulant rivaroxaban is indicated in prevention and treatment of venous thromboembolism (VTE). A 60-year-old male patient complained of bilateral ptosis after administration of rivaroxaban for deep vein thrombosis (DVT). Myasthenia gravis (MG) was confirmed by positive serum antiacetylcholine receptor antibody test. No mediastinal thymoma was found. The ocular myasthenia reversed after discontinuing rivaroxaban treatment. Nevertheless, ptosis recurred and chronic oral pyridostigmine bromide treatment was necessary. The mechanism of MG development by rivaroxaban therapy is not completely understood. The development of rivaroxaban-induced autoimmune disease could be based on cross-reactivity between antibodies against rivaroxaban-derived antigens or by T-cell activation. To our knowledge, this report of ocular myasthenia by rivaroxaban administration is the first in the literature. Despite the benefits of rivaroxaban, it is important to recognize unexpected immune-related adverse events.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. San Norberto EM, García-Saiz I, Gutiérrez D, et al. Ocular Myasthenia Induced by Rivaroxaban in Patient with Deep Vein Thrombosis. Ann Vasc Surg. 2018. PMID: 29455019. doi:10.1016/j.avsg.2017.11.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。